心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2017 EHRA/ESC共识文件：心脏瓣膜病相关性房颤的抗栓治疗

2017-11-01 欧洲心律学会 Europace. 2017 Nov 1;19(11):1757-1758.

心脏瓣膜病房颤抗栓治疗

2017年11月，欧洲心律学会(EHRA)联合欧洲心脏病学会(ESC)共同发布了心脏瓣膜病相关性房颤的抗栓治疗共识。本文主要总结了该领域的当前进展并针对这些患者的管理提供了基于循证医学的知道建议。

中文标题：

2017 EHRA/ESC共识文件：心脏瓣膜病相关性房颤的抗栓治疗

英文标题：

Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis

发布机构：

欧洲心律学会

发布日期：

2017-11-01

简要介绍：

2017年11月，欧洲心律学会(EHRA)联合欧洲心脏病学会(ESC)共同发布了心脏瓣膜病相关性房颤的抗栓治疗共识。本文主要总结了该领域的当前进展并针对这些患者的管理提供了基于循证医学的知道建议。

 

拓展指南：与房颤相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2017 EHRA/ESC共识文件：心脏瓣膜病相关性房颤的抗栓治疗)] GetToolGuiderByIdResponse(projectId=1, id=239281c00151e6c5, title=2017 EHRA/ESC共识文件：心脏瓣膜病相关性房颤的抗栓治疗, enTitle=Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, guiderFrom=Europace. 2017 Nov 1;19(11):1757-1758., authorId=null, author=, summary=2017年11月，欧洲心律学会(EHRA)联合欧洲心脏病学会(ESC)共同发布了心脏瓣膜病相关性房颤的抗栓治疗共识。本文主要总结了该领域的当前进展并针对这些患者的管理提供了基于循证医学的知道建议。 , cover=, journalId=null, articlesId=null, associationId=206, associationName=欧洲心律学会, associationIntro=欧洲心律学会（EHRAE,uropean Heart Rhythm Association)是欧洲心脏病学会的分支，致力于心律失常的预防与管理，以减少心律失常对患者的影响,减少心源性猝死。官方杂志《欧洲心律失常杂志》影响因子为1.839, copyright=0, guiderPublishedTime=Wed Nov 01 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>2017年11月，欧洲心律学会(EHRA)联合欧洲心脏病学会(ESC)共同发布了心脏瓣膜病相关性房颤的抗栓治疗共识。本文主要总结了该领域的当前进展并针对这些患者的管理提供了基于循证医学的知道建议。 </P> <P> </P>拓展指南：<strong>与<font color=red>房颤</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=04ad11c00151229a" title="2017 EHRA共识文件：心房颤动的筛查" target=_blank>2017 EHRA共识文件：心房颤动的筛查</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=f42101c001a48930" title="2016 SBC指南：心房颤动（执行纲要）" target=_blank>2016 SBC指南：心房颤动（执行纲要）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=df8f51c001a488db" title="2017 AAFP临床实践指南：新发现房颤的药物治疗（更新版）" target=_blank>2017 AAFP临床实践指南：新发现房颤的药物治疗（更新版）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=1253e1c001a38ea1" title="2016年欧洲心脏病学会心房颤动管理指南（节选）（二）" target=_blank>2016年欧洲心脏病学会心房颤动管理指南（节选）（二）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=b1f591c001a35228" title="2017 HRS/EHRA/ECAS/APHRS/SOLAECE专家共识声明：房颤导管和外科消融" target=_blank>2017 HRS/EHRA/ECAS/APHRS/SOLAECE专家共识声明：房颤导管和外科消融</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E6%88%BF%E9%A2%A4" target=_blank>有关房颤更多指南</a></ul>, tagList=[TagDto(tagId=1639, tagName=心脏瓣膜病), TagDto(tagId=364, tagName=房颤), TagDto(tagId=3301, tagName=抗栓治疗)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6447, appHits=539, showAppHits=0, pcHits=4293, showPcHits=2346, likes=146, shares=16, comments=5, approvalStatus=1, publishedTime=Fri Nov 10 21:53:58 CST 2017, publishedTimeString=2017-11-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Nov 10 21:53:58 CST 2017, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 11:32:00 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 EHRA/ESC共识文件：心脏瓣膜病相关性房颤的抗栓治疗)])
2017 EHRA/ESC共识文件：心脏瓣膜病相关性房颤的抗栓治疗
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1057557, encodeId=2eea105e557a4, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:22:46 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954661, encodeId=adf995466157, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:27:32 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265521, encodeId=1a56265521f0, content=学习和应用房颤治疗共识., beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Nov 30 07:20:12 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262183, encodeId=67d9262183cf, content=心脏瓣膜病相关性房颤., beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Nov 18 07:29:21 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260488, encodeId=13a6260488f8, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sat Nov 11 10:15:24 CST 2017, time=2017-11-11, status=1, ipAttribution=)]
    2021-10-04 H8888888

    不错 谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1057557, encodeId=2eea105e557a4, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:22:46 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954661, encodeId=adf995466157, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:27:32 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265521, encodeId=1a56265521f0, content=学习和应用房颤治疗共识., beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Nov 30 07:20:12 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262183, encodeId=67d9262183cf, content=心脏瓣膜病相关性房颤., beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Nov 18 07:29:21 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260488, encodeId=13a6260488f8, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sat Nov 11 10:15:24 CST 2017, time=2017-11-11, status=1, ipAttribution=)]
    2021-04-07 ms6000001015893838

    资料好好，但无法分享，遗憾！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1057557, encodeId=2eea105e557a4, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:22:46 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954661, encodeId=adf995466157, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:27:32 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265521, encodeId=1a56265521f0, content=学习和应用房颤治疗共识., beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Nov 30 07:20:12 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262183, encodeId=67d9262183cf, content=心脏瓣膜病相关性房颤., beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Nov 18 07:29:21 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260488, encodeId=13a6260488f8, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sat Nov 11 10:15:24 CST 2017, time=2017-11-11, status=1, ipAttribution=)]
    2017-11-30 jyzxjiangqin

    学习和应用房颤治疗共识.

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1057557, encodeId=2eea105e557a4, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:22:46 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954661, encodeId=adf995466157, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:27:32 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265521, encodeId=1a56265521f0, content=学习和应用房颤治疗共识., beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Nov 30 07:20:12 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262183, encodeId=67d9262183cf, content=心脏瓣膜病相关性房颤., beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Nov 18 07:29:21 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260488, encodeId=13a6260488f8, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sat Nov 11 10:15:24 CST 2017, time=2017-11-11, status=1, ipAttribution=)]
    2017-11-18 jyzxjiangqin

    心脏瓣膜病相关性房颤.

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1057557, encodeId=2eea105e557a4, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:22:46 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954661, encodeId=adf995466157, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:27:32 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265521, encodeId=1a56265521f0, content=学习和应用房颤治疗共识., beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Nov 30 07:20:12 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262183, encodeId=67d9262183cf, content=心脏瓣膜病相关性房颤., beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Nov 18 07:29:21 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260488, encodeId=13a6260488f8, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sat Nov 11 10:15:24 CST 2017, time=2017-11-11, status=1, ipAttribution=)]
    2017-11-11 Y—xianghai

    学习了新知识

    0

相关指南

【合集】ASE及AHA/ACC心脏瓣膜病相关指南中文版翻译合集

暂未更新 · 2017-03-03

2014 年美国心脏瓣膜病指南解读

美国心脏协会(AHA,American Heart Association) · 2015-09-30

EAE/ASE 超声心动图在心脏瓣膜病经导管介入治疗新技术中应用的建议

美国超声心动图学会(ASE,American Society of Echocardiography) · 2011-09-01